acute lymphoblastic leukemia[J].Clin Cancer Res,2005,11(24 Pt 1):86618668.
[10]STEINBACH D，WITTIG S，CARIO G，et al.The multidrug resistance associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and Tcell immunophenotype [J].Blood，2003，102(13):44934498.
[11]VALERA E T，SCRIDELI C A，QUEIROZ R G,et al.Multiple drug resistance protein (MDR1)，multidrug resistancerelated protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia[J].Sao Paulo Med J，2004,122(4):166171.
[12]GURBUXANI S,SINGH A L,RAINA V,et al.Significance of MDR1,MRP1,GSTpi and GSTmu mRNA expressionin acute lymphoblastic leukemia in Indian patients[J].Cancer Lett,2001,167(l):7383.
[13]SWERTS K，de MOERLOOSE B，DHOOGE C，et al.Prognostic significance of multidrug resistancerelated proteins in childhood acute lymphoblastic leukaemia[J].Eur J Cancer,2006,42(3):295309.
[14]SCHAICH M，SOUCEK S，THIEDE C，et al.MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia[J].Br J Haematol,2005,128(3):324332.
[15]HUH H J，PARK C J，JANG S，et al.Prognostic significance of multidrug resistance gene 1 (MDR1)，multidrug resistancerelated protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia[J].J Korean Med Sci,2006，21(2):253258.
[16]于萍，侯柯佐，郝杰,等.急性白血病MRP1与LRP的表达及临床意义[J].中国医科大学学报，2004,33(1)：6163.
[17]KURATA M，HASEGAWA M，NAKAGAWA Y,et al.Expression dynamics of drug resistance genes，multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes[J].Exp Mol Pathol,2006,81(3):249254.
[18]GALIMBERTI S，CERVETTI G，GUERRINI F,et al.Quantitative molecular monitoring of BCRABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment[J].Cancer Gen
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文